Datroway (datopotamab deruxtecan) is the first TROP2-directed therapy approved for advanced lung cancer in the U.S.

Expansion plans for the Leicester Royal Infirmary (LRI) have emerged in a bid to meet a growing need for cancer treatment.

Cambridge Healthcare Innovations (CHI) announced the availability of its dry powder inhaler (DPI) engine for clinical trials ...

Over the past few years, glutathione has surged in popularity, especially after making a mark in Indian pop culture through ...

The current clinical evidence of intravenous glutathione for skin lightening is limited. In most countries, IV glutathione is approved only for severe liver disorders and for prevention of ...

The parenteral nutrition market is growing rapidly, driven by chronic disease prevalence, aging populations, and innovations ...